LONDON - Shionogi & Co., Ltd. (TYO:4507) has reported positive outcomes from its Phase 2a human challenge trial for an investigational oral antiviral candidate targeting Respiratory Syncytial Virus ...
The VDH and Scott are advocating for people to get their vaccinations before winter. Scott said he has received his COVID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback